Skip to main content
. 2017 Dec 14;2(1):e000096. doi: 10.1136/bmjophth-2017-000096

Table 3.

Mean data for all participants at baseline, after 6 months of TES and and at 12 months

Parameter Baseline 6 months (treatment period) 12 months (observation period)
Visual acuity (letters) C: 72.3±5.9
T: 71.2±4.8
C: 73.4±5.1
T: 72.1±4.4
P=0.58
C: 71.3±6.1
T: 73.9±3.5
P=0.77
Microperimetry (db) C: 11.8±2.3
T: 11.6±2.4
C: 11.8±2.5
T: 12.0±2.6
P=0.68
C: 10.5±2.6
T: 10.5±2.4
P=0.43
Goldmann visual fields (sr) C: 1.09±0.27
T: 1.14±0.29
C: 1.25±0.30
T: 1.36±0.33
P=0.58
C: 1.27±0.27
T: 1.48±0.36
P=0.91
Central retinal thickness OCT (μm) C: 200±11
T: 190±15
C: 193±14
T: 186±14
P=0.91
C: 184±14
T: 184±14
P=0.52
Fundus autofluorescence (μm) C: 1577±141
T: 1681±153
C: 1647±91
T: 1669±165
P=0.16
C: 1563±189
T: 1469±177
P=0.64

Figures are mean±SEM.

C, control eye; OCT, optical coherence tomography; sr, steradians; T, treated eye.